Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1976-06-10
1978-06-20
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
260521H, 560143, A61K 3160
Patent
active
040962520
ABSTRACT:
2-OR-4-trifluoromethylbenzoic acid wherein R is H or acyl.
The compounds are useful in the treatment of pathological cardiovascular conditions, particularly in the prophylaxis of the thromboembolic diseases.
The compounds are made by reacting m-trifluoromethyl phenol with potassium carbonate and carbon dioxide at an elevated temperature and pressure and, if desired, acetylating the 2-OH compound thus obtained or reacting it with a phosphonating agent.
The invention also embraces pharmaceutical compositions in which the compounds constitute the effective agent and a method of treatment.
REFERENCES:
patent: 3019253 (1962-01-01), Hauptschein
Barra Emilia Francia
Moga Antonio Carmelo Marin
Fan Jane T.
J. Uriach & Cia S.A.
Rotman Alan L.
Striker Michael J.
LandOfFree
4-Trifluoromethylbenzoic acid derivatives as thromboembolic agen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-Trifluoromethylbenzoic acid derivatives as thromboembolic agen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-Trifluoromethylbenzoic acid derivatives as thromboembolic agen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1134728